Evidence map›Paper›PMID 41128425›Full record

ArticleJournal of clinical apheresis2025

Streamlining Apheresis: A Dual-Intervention Quality Improvement Initiative to Increase the Efficiency in Stem Cell Collection.

Ivy E Verriet, Renee Dickey, Sue Sinclair, Karla Schebesch, Shona Philip, Anargyros Xenocostas, Uday Deotare

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Journal of clinical apheresis, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Ivy E VerrietDepartment of Medicine, Schulich School of Medicine and Dentistry, Western University, London, Canada.ORCID https://orcid.org/0000-0001-5246-8746
Renee DickeyBlood and Marrow Transplant Program, London Health Sciences Centre, London, Canada.
Sue SinclairBlood and Marrow Transplant Program, London Health Sciences Centre, London, Canada.
Karla SchebeschBlood and Marrow Transplant Program, London Health Sciences Centre, London, Canada.
Shona PhilipDepartment of Medicine, Schulich School of Medicine and Dentistry, Western University, London, Canada.
Anargyros XenocostasDepartment of Medicine, Schulich School of Medicine and Dentistry, Western University, London, Canada.
Uday DeotareDepartment of Medicine, Schulich School of Medicine and Dentistry, Western University, London, Canada.ORCID https://orcid.org/0000-0001-9391-4204

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Autologous stem cell transplantation (ASCT) requires efficient collection of peripheral blood stem cells. At London Health Sciences Centre (LHSC), high-risk multiple myeloma patients are routinely booked for three-day apheresis collections to meet higher CD34+ cell count targets, though many do not require all scheduled days, leading to resource inefficiencies. A quality improvement initiative was implemented to reduce unnecessary apheresis sessions through two interventions: (1) lowering CD34+ cell count target thresholds (from 6 × 10

Indexed as

Blood Component RemovalMultiple MyelomaQuality ImprovementAntigens, CD34FemaleHumansMaleMiddle AgedTransplantation, AutologousAntigens, CD34apheresisautologous stem cell transplantCD34+ cell collection targetquality improvement

Identifiers

PMID41128425
PMCPMC12548524

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.